title: Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+acute lymphoblastic leukemia with the T315I mutation.
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
authors.forename: Masahiko
authors.initials: M
authors.lastname: Sumi
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.|b Department of Hematology , Kanazawa University Hospital , Kanazawa , Japan.
authors.forename: Keijiro
authors.initials: K
authors.lastname: Sato
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
authors.forename: Hiroko
authors.initials: H
authors.lastname: Kaiume
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
authors.forename: Wataru
authors.initials: W
authors.lastname: Takeda
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
authors.forename: Takehiko
authors.initials: T
authors.lastname: Kirihara
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
authors.forename: Toshimitsu
authors.initials: T
authors.lastname: Ueki
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Hiroshima
authors.affiliation: a Department of Hematology , Nagano Red Cross Hospital , Nagano , Japan.
authors.forename: Hikaru
authors.initials: H
authors.lastname: Kobayashi
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D003131:Combined Modality Therapy; D036101:Cord Blood Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006086:Graft vs Host Disease; D006650:Histocompatibility Testing; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D060046:Maintenance Chemotherapy; D008875:Middle Aged; D009154:Mutation; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D012008:Recurrence; D019233:Retreatment; D019172:Transplantation Conditioning; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D016898:Interferon-alpha; D016044:Fusion Proteins, bcr-abl